Up to a third of your patients needing ventilatory support may be mask-intolerant.
Whether due to anxiety, injury, or even a beard, using mask-based therapies with these patients can risk treatment failures, increased cost of care, and escalation of care.
Vapotherm high velocity therapy provides proven ventilatory support without the need for a mask. This mask-free respiratory tool blends the comfort of humidified high flow with the ventilatory support of NIV.
Mask-Free NIV is an approach that rethinks ventilatory support with patient comfort and compliance in mind.
Vapotherm’s Precision Flow system is unique. This mask-free form of ventilatory support blends the comfort of humidified high flow with the ventilatory support of NIV, and is the only system to earn placement in its FDA product category.
With high velocity therapy, the inventors of high flow bring you an advanced form of high flow nasal cannula. High velocity therapy offers the comfort and clinical simplicity of high flow with efficient ventilatory and oxygenation support needed for patients with acute respiratory distress.
As an advanced form of high flow nasal cannula with precise controls, EMR connectivity, and versatile treatment options — high velocity therapy has become a proven tool at the frontlines of the COVID-19 pandemic.
High velocity therapy is backed by a large and growing body of research across patient populations from COPD patients in your Emergency Department, to many of your most delicate patients in Neonatal Intensive Care.
For adult patients, high velocity therapy provides ventilatory support without the need for a mask or high pressures.
For your smallest patients, our open system, precision controls, and soft nasal cannula offer a clinical alternative to nCPAP that doesn’t prohibit feeding or kangaroo care.
“We initially decided to start using the Vapotherm in our Emergency Department because we were educated on the fact that not all patients who are having a COPD exacerbation necessarily need non-invasive positive pressure ventilation. Now, we use the Vapotherm instead to rescue these patients much more comfortably and less invasively.”
Shirley Gresham, RRT, RCP
Cardiopulmonary Supervisor
Norman Regional Health System
Vapotherm high velocity therapy is a fast and safe approach for patient populations from premature neonates to hypercapnic COPD patients. Trusted and available in more than 40 countries.
Many companies offer you scores of tools for a variety of patients.
We offer you one adaptable solution for a variety of patient needs.
From ED to NICU, learn how one respiratory therapy can support multiple areas of care.
Want more? Join Vapotherm Academy https://academy.vapotherm.com/